CD14 and amyotrophic lateral sclerosis: Finally, the increased sCD14 levels reflect increased pro-inflammatory activation of monocytes/macrophages/microglia in ALS patients, and CD14 on activated myeloid cells could represent a potentially significant therapeutic target.